Literature DB >> 9118501

Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia. A serial intravascular ultrasound study.

R Kornowski1, G S Mintz, K M Kent, A D Pichard, L F Satler, T A Bucher, M K Hong, J J Popma, M B Leon.   

Abstract

BACKGROUND: The increased risk of restenosis after catheter-based coronary interventions in diabetic patients has not been determined. Intravascular ultrasound (IVUS) has shown that the decrease in arterial area is responsible for most of the late lumen loss in nonstented lesions and that intimal hyperplasia is responsible for all of the late lumen loss in stented lesions. METHODS AND
RESULTS: Serial (postintervention and follow-up at 5.6 +/- 3.3 months) IVUS was used to study 251 native coronary lesions in 241 patients; 63 patients had treated diabetes mellitus (oral hypoglycemic drugs or insulin). Interventional procedures included percutaneous transluminal coronary angioplasty, directional or rotational atherectomy, excimer laser angioplasty, or Palmaz-Schatz stents. The external elastic membrane (EEM), stent, and lumen areas were measured. The plaque+media (P+M) area in nonstented lesions was calculated as EEM minus lumen area, and the intimal hyperplasia (IH) area in stented lesions was calculated as stent minus lumen area. The anatomic slice selected for serial analysis had an axial location within the target lesion at the smallest follow-up lumen area. Nonstented lesions in diabetics and nondiabetics had a similar decrease in EEM cross-sectional area (CSA; 1.9 +/- 2.8 versus 1.8 +/- 4.2 mm2; P = .6350). However, nonstented lesions in diabetics had a greater increase in P+M CSA (1.3 +/- 2.8 versus 0.6 +/- 2.5 mm2, P = .0720), and the increase in P+M CSA contributed a greater percentage to the decrease in lumen CSA. In stented lesions, the decrease in lumen CSA (5.2 +/- 2.5 versus 2.0 +/- 2.3 mm2) and the increase in IH CSA (5.0 +/- 2.8 versus 1.8 +/- 2.0 mm2) were greater in diabetics than nondiabetics (P = .0009 and P = .0007, respectively). These findings were even more striking in (nonstented and stented) restenotic lesions.
CONCLUSIONS: Serial IVUS analysis showed that the main reason for increased restenosis in diabetes mellitus was exaggerated intimal hyperplasia in both stented and nonstented lesions.

Entities:  

Mesh:

Year:  1997        PMID: 9118501     DOI: 10.1161/01.cir.95.6.1366

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  57 in total

Review 1.  Revascularization strategies in patients with diabetes: evolving concepts.

Authors:  J J Brennan; H S Cabin
Journal:  J Nucl Cardiol       Date:  2000 Mar-Apr       Impact factor: 5.952

Review 2.  Percutaneous coronary intervention in diabetics.

Authors:  Juhana Karha; Deepak L Bhatt
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

3.  Mechanisms related to NO-induced motility in differentiated rat aortic smooth muscle cells.

Authors:  Qinghua Pu; Daming Zhuang; Shalini Thakran; Aviv Hassid
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-10-29       Impact factor: 4.733

Review 4.  C-Peptide in insulin resistance and vascular complications: teaching an old dog new tricks.

Authors:  Dennis Bruemmer
Journal:  Circ Res       Date:  2006-11-24       Impact factor: 17.367

5.  Approaches to treatment effect heterogeneity in the presence of confounding.

Authors:  Sarah C Anoke; Sharon-Lise Normand; Corwin M Zigler
Journal:  Stat Med       Date:  2019-03-31       Impact factor: 2.373

Review 6.  The role of PCI and CABG in the management of coronary artery disease in patients with diabetes.

Authors:  Robert L Frye; Malcolm R Bell; Hartzell V Schaff; Richard Holubkov; Katherine M Detre
Journal:  Curr Diab Rep       Date:  2002-02       Impact factor: 4.810

Review 7.  Percutaneous versus surgical interventions for coronary artery disease in those with diabetes mellitus.

Authors:  Ozlem Soran
Journal:  Curr Cardiol Rep       Date:  2013-01       Impact factor: 2.931

8.  Chronic insulin treatment amplifies PDGF-induced motility in differentiated aortic smooth muscle cells by suppressing the expression and function of PTP1B.

Authors:  Daming Zhuang; Qinghua Pu; Bogdan Ceacareanu; Yingzi Chang; Madhulika Dixit; Aviv Hassid
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-02       Impact factor: 4.733

9.  Association of elevated fasting glucose with lower patency and increased major adverse limb events among patients with diabetes undergoing infrapopliteal balloon angioplasty.

Authors:  Satinder Singh; Ehrin J Armstrong; Walid Sherif; Bejan Alvandi; Gregory G Westin; Gagan D Singh; Ezra A Amsterdam; John R Laird
Journal:  Vasc Med       Date:  2014-06-17       Impact factor: 3.239

10.  Relative resistance to Mammalian target of rapamycin inhibition in vascular smooth muscle cells of diabetic donors.

Authors:  Daniel J Lightell; T Cooper Woods
Journal:  Ochsner J       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.